MaxCyte Q1 2026 Earnings EPS Beat Highlights Operational Cost Discipline Amid Revenue Disclosure Gaps PHGE Q4 2025 Earnings Severe EPS Miss as BiomX Continues Clinical Development BETR Q1 2026 Earnings WiderthanExpected Loss as Company Navigates Challenging Market CSL Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency BNTX Q1 2026 Earnings NarrowerThanExpected Loss as BioNTech Focuses on Pipeline Progress Anavex Life Sciences AVXL Edges Lower Hovering Near Key Support Viemed Healthcare VMD Shows Modest Gains Tests Key Resistance Zone Avista Corporation AVA Holds Steady Near 4169 as Utility Sector Seeks Direction TWLV Holds Steady at 995 SPAC Consolidation Signals Potential for Breakout CMCO Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Lifts Results